18F-Sodium Fluoride Uptake Is a Marker of Active Calcification and Disease Progression in Patients With Aortic Stenosis
Author(s) -
Marc R. Dweck,
William Jenkins,
Alex Vesey,
Mark A.H. Pringle,
Calvin Chin,
Tamir Malley,
William J.A. Cowie,
Vasiliki Tsampasian,
Hamish Richardson,
Alison Fletcher,
William Wallace,
Renzo Pessotto,
Edwin J.R. van Beek,
Nicholas A. Boon,
James H.F. Rudd,
David E. Newby
Publication year - 2014
Publication title -
circulation cardiovascular imaging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.584
H-Index - 99
eISSN - 1942-0080
pISSN - 1941-9651
DOI - 10.1161/circimaging.113.001508
Subject(s) - medicine , calcification , sodium fluoride , osteocalcin , stenosis , alkaline phosphatase , pathology , fluoride , chemistry , inorganic chemistry , biochemistry , enzyme
18F-Sodium fluoride (18F-NaF) and 18F-fluorodeoxyglucose (18F-FDG) are promising novel biomarkers of disease activity in aortic stenosis. We compared 18F-NaF and 18F-FDG uptake with histological characterization of the aortic valve and assessed whether they predicted disease progression.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom